1 July 2025 in Nature Communications
Bats are reservoirs of emerging zoonotic viruses that may cause severe disease in humans and agricultural animals. However, it is poorly understood how bats can tolerate diverse viral infections. Here, we characterized type I interferon response pathways in kidney cell lines derived from two divergent bat species, Pteropus alecto and Eptesicus fuscus, identifying distinct mechanisms underlying their enhanced control of viral infection. We demonstrate the critical roles of STAT1/STAT2 in IFNβ signaling, along with species-specific adaptations that contribute towards a steady and ready antiviral state. Unlike in humans, bat IFNβ signaling processes resist the immune antagonistic properties of MERS-CoV which further explains the ability of bats to tolerate coronavirus infections. Transcriptomic analysis on interferon stimulated cell lines identified canonical and non-canonical interferon stimulated genes including two differentially expressed genes, IFIT1 and GBP1, that exhibit enhanced antiviral activity against a wide range of viruses, including the bat-derived Eptesipoxvirus. We have identified a functional (AV1) motif within E. fuscus GBP1 that restricts Eptesipoxvirus replication. Ultimately, our work provides important insights into the evolution of enhanced interferon-mediated antiviral responses in bats, contributing to their ability to resist viral diseases.
4 October 2025 in bioRxiv
Enteroviruses are a widespread and diverse set of pathogens responsible for over ∼1 billion human infections annually. Upon cell entry, translation of the virus genome is mediated by an internal ribosome entry site (IRES) in the 5’ untranslated region (UTR). Despite early identification of the poliovirus IRES, structure determination has been hampered by the flexibility and complexity of the RNA (∼450 nt, five structured domains), the requirement for almost all of the eukaryotic initiation factors (eIFs), and additional dependency on PCBP2 for trans-activation. As a result, there is little mechanistic information on how enterovirus Type 1 IRESs recruit and direct translational machinery. To address this, here we reconstitute human translation initiation on a model poliovirus IRES and examine 48S complexes by electron cryo-microscopy (cryo-EM). Our structures reveal a novel set of interactions between the IRES and the translation machinery. Domain IVc contacts uS19 and uS13 on the small ribosomal subunit, and the conserved apical GNRA tetraloop interacts directly with the initiator tRNA during start-codon recognition. We demonstrate that disruption of these contacts causes defects in IRES-driven translation and virus replication. Together, our results define the structural and molecular basis for translation initiation on the Type 1 IRES, and highlight the potential for RNA-RNA tertiary interactions as new targets for antiviral therapeutics.
26 November 2024 in Research Square
Bats are reservoirs of emerging zoonotic viruses of concern that cause severe disease in humans and agricultural animals. However, it is poorly understood how bats are able to tolerate diverse viral infections, knowledge that could help pave the way for new therapeutic strategies. Here, we characterized antiviral pathways in two divergent bat species, Pteropus alecto and Eptesicus fuscus, identifying unique bat-specific mechanisms underlying their enhanced antiviral tolerance. We demonstrate the critical roles of STAT1 and STAT2 in IFNβ signaling, along with species-specific adaptations that collectively contribute towards a “steady and ready” antiviral state in bat cells. Unlike in humans, we find that bat interferon signalling processes resist the immune antagonistic properties of viruses like MERS-CoV which further explains the ability of bats to tolerate coronavirus infections. Using transcriptomic analysis, we identified canonical and non-canonical interferon stimulated genes (ISGs) including two key bat genes, IFIT1 and GBP1. Compared to their human orthologs, we show that bat IFIT1 and GBP1 exhibit enhanced antiviral activity against a wide range of RNA and DNA viruses, including coronaviruses and additional bat-derived poxviruses (e.g., Eptesipoxvirus). Ultimately, our work provides important insights into the evolution of enhanced interferon-mediated antiviral responses in bats, contributing to their unique ability to resist viral diseases.